Sunshine Biopharma Inc (SBFM)
0.0665
+0.01
(+8.84%)
USD |
NASDAQ |
Apr 16, 14:48
Sunshine Biopharma Research and Development Expense (Quarterly): 0.8163M for Dec. 31, 2023
Research and Development Expense (Quarterly) Chart
Historical Research and Development Expense (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 0.8163M |
| September 30, 2023 | 0.238M |
| June 30, 2023 | 0.3686M |
| March 31, 2023 | 0.4329M |
| December 31, 2022 | 0.0418M |
| September 30, 2022 | 0.3625M |
| June 30, 2022 | 0.0459M |
| March 31, 2022 | 0.3617M |
| December 31, 2021 | 0.0912M |
| September 30, 2021 | 0.2225M |
| June 30, 2021 | 0.1918M |
| March 31, 2021 | 0.1668M |
| December 31, 2020 | 0.0017M |
| September 30, 2020 | 0.00 |
| June 30, 2020 | 0.00 |
| March 31, 2020 | 0.00 |
| December 31, 2019 | 0.00 |
| September 30, 2019 | 0.0152M |
| June 30, 2019 | |
| March 31, 2019 | |
| December 31, 2018 | 0.0128M |
| September 30, 2018 | 0.00 |
| June 30, 2018 | |
| March 31, 2018 | |
| December 31, 2017 |
| Date | Value |
|---|---|
| September 30, 2017 | |
| June 30, 2017 | |
| March 31, 2017 | |
| December 31, 2016 | 0.00 |
| September 30, 2016 | 0.00 |
| June 30, 2016 | 0.0328M |
| March 31, 2016 | |
| December 31, 2015 | 0.00 |
| September 30, 2015 | 0.0087M |
| June 30, 2015 | 0.00 |
| March 31, 2015 | |
| December 31, 2014 | 0.004M |
| September 30, 2014 | 0.00 |
| June 30, 2014 | 0.323M |
| March 31, 2014 | 0.096M |
| December 31, 2013 | 0.114M |
| September 30, 2013 | 0.00 |
| June 30, 2013 | 0.00 |
| March 31, 2013 | 0.0234M |
| December 31, 2012 | 0.00 |
| September 30, 2012 | 0.00 |
| June 30, 2012 | 0.0018M |
| March 31, 2012 | 0.00 |
| December 31, 2011 | 0.125M |
| September 30, 2011 | 0.00 |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
Dec 2019
0.8163M
Maximum
Dec 2023
0.1865M
Average
0.129M
Median
Research and Development Expense (Quarterly) Benchmarks
| Acasti Pharma Inc | 1.443M |
| Aurinia Pharmaceuticals Inc | 10.23M |
| Edesa Biotech Inc | 0.7045M |
| Lexaria Bioscience Corp | 0.2458M |
| Xenon Pharmaceuticals Inc | 41.08M |